Literature DB >> 3437827

Isolation of Campylobacter pyloridis from human gastric mucosa and characterization of the isolates.

T Itoh1, Y Yanagawa, M Shingaki, M Takahashi, A Kai, M Ohashi, G Hamana.   

Abstract

Biopsy specimens of human gastric mucosa of patients with gastric complaints and subjected to endoscopic examination were cultured microaerobically, and Campylobacter pyloridis was detected in 46 out of 80 cases (57.5%). The organism was found in 13 out of 22 patients with gastritis, 11 out of 16 with gastric ulcer scar, 7 out of 16 with gastric ulcer, 3 out of 9 with gastric polyp, 4 out of 5 with gastric carcinoma, 2 out of 2 with esophagus carcinoma, and 6 out of 9 with other gastric diseases. The isolates were identified as C. pyloridis, demonstrating its characteristic features such as positive for oxidase and catalase, negative for reduction of nitrite and nitrate, positive for urease, no growth at 25 C, growth at 37 C, not tolerant to 1% glycine, and resistant to nalidixic acid. Positive alkaline phosphatase activity was considered as an additional feature characteristic for the strains of C. pyloridis. The major cellular fatty acids were tetradecanoic acid and 19-carbon-cyclopropane acid. This pattern is unique among Campylobacter species. The survival of the organism for a longer period than 60 min at pH 2.5 indicates its significant resistance to acidic environment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3437827     DOI: 10.1111/j.1348-0421.1987.tb03121.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  17 in total

1.  Abstracts of selected papers presented at the 75th general meeting of the Japanese Society of Gastroenterology. March 27-29, 1989, Yokohama, Japan.

Authors: 
Journal:  Gastroenterol Jpn       Date:  1991-02

2.  Effect of ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.

Authors:  S Hayashi; T Sugiyama; A Yachi; K Yokota; Y Hirai; K Oguma; N Fujii
Journal:  J Gastroenterol       Date:  1997-10       Impact factor: 7.527

3.  Reproducibility of tolerance tests that are useful in the identification of campylobacteria.

Authors:  S L On; B Holmes
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

4.  Activity of cefixime against Helicobacter pylori and affinities for the penicillin-binding proteins.

Authors:  F Ikeda; Y Yokota; Y Mine; M Tatsuta
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

5.  Effect of inoculum size on the phenotypic characterization of Campylobacter species.

Authors:  S L On; B Holmes
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

6.  Minimal standards for describing new species belonging to the families Campylobacteraceae and Helicobacteraceae: Campylobacter, Arcobacter, Helicobacter and Wolinella spp.

Authors:  Stephen L W On; William G Miller; Kurt Houf; James G Fox; Peter Vandamme
Journal:  Int J Syst Evol Microbiol       Date:  2017-10-16       Impact factor: 2.747

7.  Comparison of the nucleic acids of helical and coccoid forms of Helicobacter pylori.

Authors:  S Narikawa; S Kawai; H Aoshima; O Kawamata; R Kawaguchi; K Hikiji; M Kato; S Iino; Y Mizushima
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

8.  Analysis of immunoglobulin A antibodies to Helicobacter pylori in serum and gastric juice in relation to mucosal inflammation.

Authors:  S Hayashi; T Sugiyama; K Yokota; H Isogai; E Isogai; K Oguma; M Asaka; N Fujii; Y Hirai
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori.

Authors:  G Geis; H Leying; S Suerbaum; W Opferkuch
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

10.  Strain variation in Campylobacter pylori detected by numerical analysis of one-dimensional electrophoretic protein patterns.

Authors:  R J Owen; M Costas; D D Morgan; S L On; L R Hill; A D Pearson; D R Morgan
Journal:  Antonie Van Leeuwenhoek       Date:  1989-03       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.